Previous interest in high-density lipoproteins (HDLs) focused on their possible protective
role in atherosclerotic cardiovascular disease (ASCVD). Evidence from genetic studies and …

Abstract Apolipoprotein A1 (ApoA1) is a member of the Apolipoprotein family of proteins. It's
a vital protein that helps in the production of high-density lipoprotein (HDL) particles, which …

Lipoproteins in cerebrospinal fluid (CSF) of the central nervous system (CNS) resemble
plasma high-density lipoproteins (HDLs), which are a compositionally and structurally …

Cardiovascular disease (CVD) is the leading cause of death in Western countries. A low
HDL-C is associated with the development of CVD. However, recent epidemiology studies …

Therapeutic approaches to reduce atherogenic lipid and lipoprotein levels remain the most
effective and assessable strategies to prevent and treat cardiovascular disease. The …

Rheumatoid arthritis (RA) is an autoimmune inflammatory disease, of which the leading
cause of death is cardiovascular disease (CVD). The levels of total cholesterol (TC), low …

Preeclampsia (PE) is linked to an overall increased cardiovascular risk for both the mother
and child. Functional impairment of high-density lipoproteins (HDL) may contribute to the …

High-density lipoproteins (HDL) play a key role in cholesterol homeostasis maintenance in
the central nervous system (CNS), by carrying newly synthesized cholesterol from astrocytes …

Background High‐density lipoprotein (HDL) particle concentration likely outperforms HDL
cholesterol in predicting atherosclerotic cardiovascular events. Whether size‐based HDL …

Inflammation and oxidative stress are essential components in a myriad of pathogenic
entities that lead to metabolic and chronic diseases. Moreover, inflammation in its different …